NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Obesity; EndocrinePituitary DysfunctionBone Health
Interventions
DIAGNOSTIC_TEST

Dexa or Biompedance analysis with clinical and biochemical evaluations

All patients will undergo body composition study with DXA or Bioimpedance analysis which are the gold standard to determine % of fat mass and fat free mass, basal biochemical examinations and oral glucose tolerance test (OGTT), and clinical evaluation with waist circumference measurement. Moreover, all patients will undergo REMS ultrasound, TBS and BSI evaluation at DXA scan and hand grip test. In addition, all patients will undergo to clinical evaluation with specific nutritional, physical activity and sleep quality questionnaire assessments and an additional volume of blood.

All Listed Sponsors
collaborator

Federico II University

OTHER

collaborator

University of Catanzaro

OTHER

collaborator

Istituto Auxologico Italiano

OTHER

lead

IRCCS San Raffaele

OTHER

NCT06540820 - NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY | Biotech Hunter | Biotech Hunter